Norristown, PA, United States of America

Pamela A Lane


Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2000-2001

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Pamela A. Lane

Introduction

Pamela A. Lane is a notable inventor based in Norristown, PA (US). She has made significant contributions to the field of biotechnology, particularly in the development of polypeptides and polynucleotides. With a total of 3 patents to her name, her work has implications for therapeutic and diagnostic applications.

Latest Patents

Among her latest patents is the invention titled "Polynucleotide encoding a Mouse 7-transmembrane GPR43 receptor." This patent discloses the mouse GPR43 polypeptides and polynucleotides, along with methods for producing such polypeptides through recombinant techniques. The patent also outlines methods for utilizing these mouse GPR43 polypeptides and polynucleotides in therapy and diagnostic assays. Another significant patent is for the "Human bombesin receptor subtype-3sb," which includes bombesin receptor subtype-3sb polypeptides and polynucleotides, as well as methods for their production and therapeutic use.

Career Highlights

Pamela A. Lane is currently associated with SmithKline Beecham Corporation, where she continues to advance her research and innovations. Her work has been instrumental in the development of new therapeutic strategies.

Collaborations

Throughout her career, Pamela has collaborated with esteemed colleagues, including Nabil A. Elshourbagy and Ping Tsui. These collaborations have further enriched her research and contributed to her success as an inventor.

Conclusion

Pamela A. Lane's contributions to biotechnology through her patents and collaborations highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in therapy and diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…